Cantitate/Preț
Produs
Total produse
Vezi coșul
The Science and Business of Drug Discovery: Demystifying the Jargon de Edward D. Zanders

The Science and Business of Drug Discovery: Demystifying the Jargon

Autor Edward D. Zanders
en Limba Engleză Paperback – 11 noi 2021
The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the twenty chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices.
The following topics are covered:
  • Different types of drugs: from small molecules to stem cells
  • Background to chemistry of small and large molecules
  • Historical background to drug discovery, pharmacology and biotechnology
  • The drug discovery pipeline: from target discovery to marketed medicine
  • Commercial aspects of drug discovery
  • Challenges to the biopharmaceutical industry and its responses
  • Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators
 
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (2) 43341 lei  6-8 săpt.
  Springer International Publishing – 11 noi 2021 43341 lei  6-8 săpt.
  Springer Us – 30 sep 2014 108229 lei  6-8 săpt.
Hardback (2) 65653 lei  6-8 săpt.
  Springer International Publishing – 10 noi 2020 65653 lei  6-8 săpt.
  Springer Us – 7 iul 2011 108712 lei  6-8 săpt.

Preț: 43341 lei

Preț vechi: 45621 lei
-5% Nou

Puncte Express: 650
Preț estimativ în valută:
8297€ • 8533$ • 6883£

Carte tipărită la comandă

Livrare economică 18 februarie-04 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030578169
ISBN-10: 303057816X
Pagini: 402
Ilustrații: XVII, 402 p. 102 illus., 20 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.64 kg
Ediția:2nd ed. 2020
Editura: Springer International Publishing
Colecția Springer
Locul publicării:Cham, Switzerland

Cuprins

Introduction.- PART 1: How Drugs are Discovered and Developed in the Pharmaceutical Industry.- Introduction to Drugs and Drug Targets.-   Background to chemistry of small and large molecules.- Laying the foundations- Drug discovery from antiquity to the twenty first century.- Part II-The drug development pipeline – discovery to testing in humans.- Drug discovery pipeline overview.- Target discovery.- Medicinal chemistry.- Biotherapeutics.- Screening for hits.- Process chemistry and formulation.- Preclinical development.- Part III-The drug development pipeline – clinical trials to marketing authorisation.- Clinical trials.- Regulatory affairs and marketing approval.- Diagnostics and personalized medicine.- Putting it All Together: a drug development case history.- Part IV- The Global Pharmaceuticals Business.- Commercial aspects of drug development.- Challenges and responses.- Part V - Professional Interactions with the Drug Discovery Industry.-Professional Interactions with the Drug Discovery Industry: Technology Transfer Executives.- Recruitment Executives.- Pharmaceutical translators and Interpreters.

Notă biografică

Dr. Edward D. Zanders has over 30 years’ experience as a scientist and research manager in both a major pharmaceutical company and in smaller biotechnology organizations. He has been responsible for a number of drug discovery programs for diseases such as asthma and rheumatoid arthritis and has been involved in research management at a senior level. He has also published extensively on subjects ranging from biochemistry and immunology to computer-aided drug design and the application of online networking to drug discovery. More recently he has written about drug targets in the human genome and a survey of drug discovery for glioblastoma. In 2004 he founded PharmaGuide Ltd, a training and consultancy company that delivers courses on the drug discovery industry to various professional groups including technology transfer executives, recruiters and technical translators. It is through delivering these courses that he has been able to develop his own way of conveying complex information about drug discovery to non scientists, while at the same time being able to communicate with PhD level scientists at their level of expertise.
 


Textul de pe ultima copertă

The Science and Business of Drug Discovery is written for those who want to learn about the biopharmaceutical industry and its products whatever their level of technical knowledge. Its aim is to demystify the jargon used in drug development, but in a way that avoids over simplification and the resulting loss of key information. Each of the twenty chapters is illustrated with figures and tables which clarify some of the more technical points being made. Also included is a drug discovery case history which draws the relevant material together into a single chapter. In recognizing that it is difficult to navigate through the many external resources dealing with drug development, the book has been written to guide the reader towards the most appropriate information sources, including those listed in the two appendices.
The following topics are covered:
  • Different types of drugs: from small molecules to stem cells
  • Background to chemistry ofsmall and large molecules
  • Historical background to drug discovery, pharmacology and biotechnology
  • The drug discovery pipeline: from target discovery to marketed medicine
  • Commercial aspects of drug discovery
  • Challenges to the biopharmaceutical industry and its responses
  • Material of specific interest to technology transfer executives, recruiters and pharmaceutical translators
 
​

Caracteristici

Written for those in drug development who want an overview Filled with illustrations figures and case histories Total coverage of drug discovery pipeline Addresses the commercial aspects as well as the challenges

Recenzii

From the reviews:
“‘The Science and Business of Drug Discovery: Demystifying the Jargon’ is an engaging, comprehensive and straightforward review of drug discovery and development. The book is ideal for anyone who wants to understand how their work fits into the overall scheme or needs to communicate with people from other specialties.” (Norman M. Goldfarb, Journal of Clinical Research Best Practices, Vol. 8 (4), April, 2012)
“A ‘thorough review of the technical and business aspects of drug discovery that can be understood by a reader with little scientific knowledge.’ … Zanders tries to use as little jargon as possible in explaining how drugs work, and he provides case histories of certain drugs. … each chapter can stand alone, letting readers choose what interests them. Enhancing the text are an excellent glossary and suggestions for further reading. … Summing Up: Recommended. Chemistry, pharmacy, and medical collections supporting upper-level undergraduates and above.” (N. Kupferberg, Choice, Vol. 49 (5), January, 2012)
“The book excellently highlights many scientific and technological developments, breakthroughs, and their impacts on pharmaceutical R&D at its various stages and thus provides interesting reading for students, professionals, and even experts in scientific disciplines relevant to drug discovery and development … . the book can also be recommended as excellent reading to all those who would like to break through the walls of esotericism of the many disciplines and technologies or expert circles involved in the pharmaceutical business.” (Klaus Müller, ChemMedChem, Vol. 7, 2012)